SUSAN ELROD: Open Payments
NPI 1063418713 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,497 in 97 payments from 17 companies in 2025. Trend: 2023 $1,765 · 2024 $2,077 · 2025 $2,497
Food & beverage: $2,428Education: $69
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $624 |
| Novartis Pharmaceuticals Corporation | 16 | $340 |
| ABBVIE INC. | 15 | $242 |
| Galderma Laboratories, L.P. | 9 | $242 |
| Regeneron Healthcare Solutions, Inc. | 7 | $238 |
| E.R. Squibb & Sons, L.L.C. | 10 | $156 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $125 |
| Organon LLC | 1 | $119 |
| Janssen Biotech, Inc. | 4 | $95 |
| Lilly USA, LLC | 4 | $87 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, COSENTYX, NEMLUVIO, Sotyktu, VTAMA, TREMFYA.
Industry payments across KY — which companies pay providers there.
